Search

Search Results

• ON THE VERSATILITY OF VON WILLEBRAND FACTOR

  Antoine Rauch, Peter Lenting

  e2013046

  2013-07-10

  https://doi.org/10.4084/mjhid.2013.046

  2984

  PDF: 1236

  HTML: 11434

• EPIDEMIOLOGY OF ACTIVATED PROTEIN C RESISTANCE AND FACTOR V LEIDEN MUTATION IN THE MEDITERRANEAN REGION

  Mehrez Mehrez M. Jadaon

  e2011037

  2011-09-08

  https://doi.org/10.4084/mjhid.2011.037

  3235

  PDF: 894

  HTML: 12974

• MUTATIONAL PROFILES OF F8 AND F9 IN A COHORT OF HAEMOPHILIA A AND HAEMOPHILIA B PATIENTS IN THE MULTI-ETHNIC MALAYSIAN POPULATION

  Maimiza Zahari, Siti Aishah Sulaiman, Zulhabri Othman, Yasmin Ayob, Faraizah Abd Karim, Rahman Jamal

  e2018056

  2018-09-01

  https://doi.org/10.4084/mjhid.2018.056

  2192

  PDF: 1139

  HTML: 983

  Figure 1: 216

  Figure 2: 238

• Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA

  Bhavya S Doshi, Valder R Arruda, Valder R Arruda

  e2020069

  2020-09-08

  https://doi.org/10.4084/mjhid.2020.069

  2313

  PDF: 2026

  HTML: 536

• CLINICAL PROFILE OF PATIENTS WITH RARE INHERITED COAGULATION DISORDERS: A RETROSPECTIVE ANALYSIS OF 67 PATIENTS FROM NORTHERN INDIA

  Sanjeev Kumar Sharma, Suman Kumar, Tulika Seth, Pravas Mishra, Narendra Agrawal, Gurmeet Singh, Avinash Singh, Manoranjan Mahapatra, Seema Tyagi, Haraprasad Pati, Renu Saxena

  e2012057

  2012-10-02

  https://doi.org/10.4084/mjhid.2012.057

  1537

  PDF: 609

  HTML: 2931

• PROTEOLYTIC PROCESSING OF VON WILLEBRAND FACTOR BY ADAMTS13 AND LEUKOCYTE PROTEASES

  Stefano Lancellotti, Maria Basso, Raimondo De Cristofaro

  e2013058

  2013-09-01

  https://doi.org/10.4084/mjhid.2013.058

  3617

  PDF: 1244

  HTML: 24282

• SEPSIS-ASSOCIATED DISSEMINATED INTRAVASCULAR COAGULATION AND THROMBOEMBOLIC DISEASE

  Nicola Semeraro, Concetta T. Ammollo, Fabrizio Semeraro, Mario Colucci

  e2010024

  2010-08-06

  https://doi.org/10.4084/mjhid.2010.024

  3624

  PDF: 1890

  HTML: 4814

• EPIDEMIOLOGY OF PROTHROMBIN G20210A MUTATION IN THE MEDITERRANEAN REGION

  Mehrez M. Jadaon

  e2011054

  2011-11-28

  https://doi.org/10.4084/mjhid.2011.054

  2888

  PDF: 1219

  HTML: 2856

• MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA Guest Editor: Giancarlo Costaman

  Davide Matino, Paul Tieu, Dr., Antony Chan

  e2020001

  2020-01-01

  https://doi.org/10.4084/mjhid.2020.001

  3571

  PDF: 1695

  HTML: 721

• SUCCESSFUL LONG TERM ERADICATION OF FACTOR VIII INHIBITOR IN PATIENTS WITH ACQUIRED HAEMOPHILIA A IN SAUDI ARABIA

  Galila F Zaher, Soheir S Adam

  e2012021

  2012-04-02

  https://doi.org/10.4084/mjhid.2012.021

  1474

  PDF: 975

  HTML: 3744

• EFFECTS OF FACTOR XIII DEFICIENCY ON THROMBOELASTOGRAPHY. THROMBELASTOGRAPHY WITH CALCIUM AND LYSIS BY ADDITION OF STREPTOKINASE IS MORE SENSITIVE THAN SOLUBILITY TESTS

  Marta E Martinuzzo

  e2016037

  2016-08-16

  https://doi.org/10.4084/mjhid.2016.037

  3223

  PDF: 1058

  HTML: 1968

  Untitled: 214

  Untitled: 232

  Untitled: 222

  Untitled: 231

  Untitled: 217

• VON WILLEBRAND FACTOR ABNORMALITIES STUDIED IN THE MOUSE MODEL: WHAT WE LEARNED ABOUT VWF FUNCTIONS

  Caterina Casari, Cecile V Denis

  e2013047

  2013-07-10

  https://doi.org/10.4084/mjhid.2013.047

  2296

  PDF: 1032

  HTML: 9690

• CIRCUMCISION IN MALES WITH BLEEDING DISORDERS

  Hassan Mansouritorghabeh, Abdollah Banihashem, Alireza Modaresi, Lida Manavifar

  e2013004

  2013-01-02

  https://doi.org/10.4084/mjhid.2013.004

  2069

  PDF: 987

  HTML: 6836

  Cover letter: 213

• VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS

  Anna M. Randi, Mike A Laffan, Richard D. Starke

  e2013060

  2013-09-02

  https://doi.org/10.4084/mjhid.2013.060

  3953

  PDF: 1678

  HTML: 8257

  Randi Fig: 234

• CHANGES OF VON WILLEBRAND FACTOR DURING PREGNANCY IN WOMEN WITHOUT AND WITH VON WILLEBRAND DISEASE

  Giancarlo Castaman

  e2013052

  2013-07-16

  https://doi.org/10.4084/mjhid.2013.052

  3373

  PDF: 1127

  HTML: 8621

• PLATELET-LEUKOCYTE INTERACTIONS : MULTIPLE LINKS BETWEEN INFLAMMATION , BLOOD COAGULATION AND VASCULAR RISK

  Chiara Cerletti, Giovanni de Gaetano, Roberto Lorenzet

  e2010023

  2010-08-06

  https://doi.org/10.4084/mjhid.2010.023

  1942

  PDF: 960

  HTML: 10599

• ROLE OF STEM CELL FACTOR IN THE REACTIVATION OF HUMAN FETAL HEMOGLOBIN

  Marco Gabbianelli, Ugo Testa

  e2009009

  2009-11-12

  1346

  PDF: 524

  HTML: 4632

• DISCOVERY OF TYPE 3 VON WILLEBRAND DISEASE IN A COHORT OF PATIENTS WITH SUSPECTED HEMOPHILIA A IN CÔTE D’IVOIRE

  Adia Eusèbe Adjambri, Sylvie Bouvier, Roseline N'guessan, Emma N’draman-Donou, Mireille Yayo-Ayé, Marie-France Meledje, Missa Louis Adjé, Duni Sawadogo

  e2020019

  2020-02-26

  https://doi.org/10.4084/mjhid.2020.019

  1650

  PDF: 1323

  HTML: 291

• CLINICAL SIGNIFICANCE OF ASSESSMENT OF THROMBOSPONDIN AND PLACENTA GROWTH FACTOR LEVELS IN PATIENTS WITH SICKLE CELL ANEMIA: TWO CENTERS EGYPTIAN STUDIES

  adel abd elhaleim hagag, Ghada Elmashad, Aml Ezzat Abd El-Lateef

  e2014044

  2014-06-29

  https://doi.org/10.4084/mjhid.2014.044

  1949

  PDF: 992

  HTML: 2315

• THROMBOTIC MICROANGIOPATHY IN HAEMATOPOIETIC CELL TRANSPLANTATION:AN UPDATE

  Evi Stavrou, Hillard Michael Lazarus

  e2010033

  2010-10-29

  https://doi.org/10.4084/mjhid.2010.033

  1740

  PDF: 1141

  HTML: 10890

• VIRAL CIRRHOSIS: AN OVERVIEW OF HAEMOSTATIC ALTERATIONS AND CLINICAL CONSEQUENCES

  Francesca Romana Ponziani, Valerio De Stefano, Antonio Gasbarrini

  e2009033

  2009-12-29

  https://doi.org/10.4084/mjhid.2009.033

  2769

  PDF: 566

  HTML: 3627

• CAUSES OF ADULT SPLANCHNIC VEIN THROMBOSIS IN THE MEDITERRANEAN AREA

  Valerio De Stefano, Tommaso Za, Angela Ciminello, Laura Betti, Elena Rossi

  e2011063

  2011-12-19

  https://doi.org/10.4084/mjhid.2011.063

  2776

  PDF: 1013

  HTML: 3736

• THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis

  Nicola Semeraro, Prof. Mario Colucci

  e2021045

  2021-06-28

  https://doi.org/10.4084/MJHID.2021.045

  2597

  PDF: 882

  HTML: 491

• PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA

  Anna Falanga, Laura Russo, Carmen J Tartari

  e2011068

  2011-12-21

  https://doi.org/10.4084/mjhid.2011.068

  1995

  PDF: 893

  HTML: 10370

  Figures 1,2,3: 281

• VASCULAR ENDOTHELIAL GROWTH FACTOR IN CHILDREN WITH THALASSEMIA MAJOR PDF

  sameh samir fahmey, Hassan Naguib, sanna Abdelshafy, rasha Alashry

  e2013044

  2013-06-05

  https://doi.org/10.4084/mjhid.2013.044

  1421

  PDF: 932

  HTML: 1145

  Figure 1 the correlation between frequency of blood transfusion and serum vascular endothelial growth factor (VEGF).: 232

• DESCRIPTIVE EPIDEMIOLOGY OF HEMOPHILIA AND OTHER COAGULATION DISORDERS IN MANSOURA , EGYPT

  Youssef Al Tonbary, Rasha ElAshry, Maysaa El Sayed Zaki

  e2010025

  2010-08-03

  https://doi.org/10.4084/mjhid.2010.025

  1982

  PDF: 999

  HTML: 1127

• CRYOGLOBULIN TEST AND CRYOGLOBULINEMIA HEPATITIS C-VIRUS RELATED

  Umberto Basile

  e2017007

  2017-01-01

  https://doi.org/10.4084/mjhid.2017.007

  4505

  PDF: 1418

  HTML: 2612

• SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM

  Zohreh Rahimi, Abbas Parsian

  e2011024

  2011-05-23

  https://doi.org/10.4084/mjhid.2011.024

  2415

  PDF: 1009

  HTML: 2412

• HIV-ASSOCIATED VENOUS THROMBOEMBOLISM

  Michele Bibas, Gianluigi Biava, Andrea Antinori

  e2011030

  2011-07-08

  https://doi.org/10.4084/mjhid.2011.030

  4676

  PDF: 1567

  HTML: 8551

• PATIENTS REFERRED FOR BLEEDING SYMPTOMS OF UNKNOWN CAUSE: DOES EVALUATION OF THROMBIN GENERATION CONTRIBUTE TO DIAGNOSIS?

  Elena Holm, Eva Zetterberg, Susanna Lövdahl, Erik Berntorp

  e2016014

  2016-02-10

  https://doi.org/10.4084/mjhid.2016.014

  3905

  PDF: 911

  HTML: 1615

• NEW STRATEGIES FOR STEM CELL MOBILIZATION

  Roberto Lemoli

  e2012066

  2012-10-03

  https://doi.org/10.4084/mjhid.2012.066

  2599

  PDF: 966

  HTML: 2586

• INCREASED VASOOCCLUSIVE CRISIS IN “O” BLOOD GROUP SICKLE CELL DISEASE PATIENTS: ASSOCIATION WITH UNDERLYING THROMBOSPONDIN LEVELS.

  M. Al Huneini, Anil Pathare

  e2017028

  2017-04-20

  https://doi.org/10.4084/mjhid.2017.028

  2263

  PDF: 1007

  HTML: 1510

• SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML

  Francesco D'Alò, Luana Fianchi, Emiliano Fabiani, Marianna Criscuolo, Mariangela Greco, Francesco Guidi, Livio Pagano, Giuseppe Leone, Maria Teresa Voso

  e2011052

  2011-11-28

  https://doi.org/10.4084/mjhid.2011.052

  3866

  PDF: 975

  HTML: 6888

• SPLANCHNIC VEIN THROMBOSIS IN THE MEDITERRANEAN AREA IN CHILDREN

  Hanaa El-Karaksy, Mona El-Raziky

  e2011027

  2011-07-08

  https://doi.org/10.4084/mjhid.2011.027

  2461

  PDF: 991

  HTML: 1717

• HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?

  Antoine Thyss, Esma Saada, Lauris Gastaud, Frédéric Peyrade, Daniel Ré

  e2014050

  2014-07-01

  https://doi.org/10.4084/mjhid.2014.050

  3051

  PDF: 1452

  HTML: 3740

  Untitled: 252

  Untitled: 258

  Untitled: 220

• Acquired von Willebrand Syndrome associated to secondary IgM MGUS emerging after Autologous Stem Cell Transplantation for AL Amyloidosis

  Victor H Jimenez-Zepeda, Hina Qamar, Adrienne Lee, Karen Valentine, Leslie Skeith

  e2017034

  2017-05-01

  https://doi.org/10.4084/mjhid.2017.034

  2796

  PDF: 1114

  HTML: 1219

• PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA

  Annarosa Cuccaro, Francesca Bartolomei, Elisa Cupelli, Stefan Hohaus

  e2014053

  2014-07-04

  https://doi.org/10.4084/mjhid.2014.053

  3527

  PDF: 2095

  HTML: 7584

• TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML

  Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi

  e2023038

  2023-06-29

  https://doi.org/10.4084/MJHID.2023.038

  2450

  PDF: 1905

  HTML: 1065

• ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children

  Ilaria Lazzareschi, Elena Rossi, Antonietta Curatola, Giovanna Capozio, Luca Benacquista, Ludovica Iezzi, Donato Rigante

  e2022008

  2022-01-01

  https://doi.org/10.4084/MJHID.2022.008

  2668

  PDF: 1270

  HTML: 1095

• PROGNOSTIC IMPACT OF WT-1 GENE EXPRESSION IN EGYPTIAN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA

  Adel Abd Elhaleim Hagag

  e2016008

  2016-01-01

  https://doi.org/10.4084/mjhid.2016.008

  4237

  PDF: 908

  HTML: 2503

• CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES

  Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi

  e2022069

  2022-08-27

  https://doi.org/10.4084/MJHID.2022.069

  3467

  PDF: 1014

  HTML: 4643

• THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA

  Xenofon Papanikolaou, Bart Barlogie, Saad Usmani

  e2011047

  2011-10-24

  https://doi.org/10.4084/mjhid.2011.047

  2624

  PDF: 862

  HTML: 1756

• Correlation to FVIII:C in two thrombin generation tests: TGA-CAT and INNOVANCE ETP

  Marcus Ljungkvist

  e2017064

  2017-11-01

  https://doi.org/10.4084/mjhid.2017.064

  2354

  PDF: 854

  HTML: 911

  Figure 2: 258

  Figure 1: 222

• CLINICAL CARE PATHWAY AND MANAGEMENT OF MAJOR BLEEDING ASSOCIATED WITH NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS: A MODIFIED DELPHI CONSENSUS FROM SAUDI ARABIA AND UAE

  Abdulrahman Al Raizah, Fakhr Alayoubi, Galal Hassan Abdelnaby, Hazzaa Alzahrani, Majid Farraj Bakheet, Mohammed A Alskaini, Rasha Buhumaid, Sameer Al Awadhi, Sara Nooruddin Kazim, Thiagarajan Jaiganesh, Zohair Al Asiri

  e2024038

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.038

  2687

  PDF: 1283

  HTML: 134

• MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.

  Maria Ilaria Del Principe

  e2016052

  2016-10-20

  https://doi.org/10.4084/mjhid.2016.052

  5230

  PDF: 1377

  HTML: 1941

  Untitled: 235

  Untitled: 218

• INFECTIONS IN MYELODYSPLASTIC SYNDROME IN RELATION TO STAGE AND THERAPY

  Giuseppe Leone, Livio Pagano

  e2018039

  2018-07-01

  https://doi.org/10.4084/mjhid.2018.039

  4470

  PDF: 1537

  HTML: 788

• CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.

  Vincenzo De Sanctis

  e2020006

  2020-01-01

  https://doi.org/10.4084/mjhid.2020.006

  4446

  PDF: 1611

  HTML: 482

• THE ROLE OF BLEEDING HISTORY AND CLINICAL MARKERS FOR THE CORRECT DIAGNOSIS OF VWD

  Alberto Tosetto

  e2013051

  2013-07-12

  https://doi.org/10.4084/mjhid.2013.051

  2597

  PDF: 967

  HTML: 4170

• GUT COLONIZATION WITH CARBAPENEM RESISTANT ENTEROBACTERIACEAE ADVERSELY IMPACTS THE OUTCOME IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES: RESULTS OF A PROSPECTIVE SURVEILLANCE STUDY

  SUPARNO CHAKRABARTI

  e2018025

  2018-05-01

  https://doi.org/10.4084/mjhid.2018.025

  4129

  PDF: 1441

  HTML: 502

• DOES INSULIN LIKE GROWTH FACTOR-1 (IGF-1) DEFICIENCY HAVE A “PROTECTIVE” ROLE IN THE DEVELOPMENT OF DIABETIC RETINOPATHY IN THALASSEMIA MAJOR PATIENTS?

  Vincenzo De Sanctis

  e2015038

  2015-05-20

  https://doi.org/10.4084/mjhid.2015.038

  2087

  PDF: 1003

  HTML: 5193